Oncology clinical trials at Subiaco

The Oncology Clinical Trial Unit at St John of God Subiaco Hospital is committed to ongoing research of cancer treatment and outcomes, ensuring our patients receive the most advanced contemporary treatment as well as contributing to the wider body of knowledge in relation to cancer.
  • Cancer is the leading cause of death in Australia, with about 1 in 2 Australian men and 1 in 3 Australian women will be diagnosed with cancer in their life.
  • Clinical trials play an essential role in discovering new and more effective treatments for cancer.
  • Outstanding research-based health care is provided to all participants involved in clinical trials and we offer comprehensive and integrated evidence-based treatment options.
 
  • Since 2001 the Oncology Clinical Trial Unit at St John of God Subiaco Hospital in collaboration with Cancer Council WA has focused on providing different treatment options, in addition to the standard of care, for people with a wide variety of cancers.
  • We are committed to ensuring our research provides opportunities and support for patients undergoing treatment for their cancer that may otherwise not be available in a non-clinical trial setting. Additionally results from these studies will inform future bedside care and hopefully improve patient outcomes. This focus has helped us become one of Australia’s top research institutes.

St John of God Subiaco Hospital
Bendat Family Comprehensive Cancer Centre

Contact details
Phone: (08) 6465 9204
Email: ClinicalTrials.Subiaco@sjog.org.au

 

Medical Oncologists
Dr Andrew Dean
A/Prof Timothy Clay
Dr Tom van Hagen 
Dr Tarek Meniawy 
Dr Daphne Tsoi 
Dr Martin Buck
Dr Mihitha Ariyapperuma

Surgical Oncologists
Prof Christobel Saunders
A/Prof Paul Cohen

Medical Registrar 
Dr Janelle Prunster
Dr Shaun Ong

Research Operations Manager
Dino Cercarelli

Research Administrative Officer
Heather McNaught

Senior Clinical Trial and Data Management Officer
Taryn Quartermaine

Clinical Trial and Data Management Officers
Melanie Cheah
Lenka Leskova
Grace Till

Clinical Trial Nurse, Oncology
Shauna Gaffey
Jennifer Fraser

Clinical Trials Assistant
Fiona Bradley

Research staff
Dr Niloufer Johansen, Research Officer (Breast)

Dr Katy Mohammadi (Breast)
Stephanie Jeffares (Gynaecology Cancer)

Research Assistant

Angela Garbin
 
Clinical Trial Liaison Officer
Dr Angela Baird

Project Manager, Clinical Trial Development
Dr Jo Youd

Medical Secretary
Jenni Wilke
 


 
Travers, N., Cronin, E., Marinova, M., Smith, P., Dean, A. Anaplastic thyroid cancer: A report of six consecutive cases treated successfully with nab-paclitaxel. Journal of Clinical Oncology, 26 May 2019
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e17586?af=R

Dean, A., Peeperkon, L., Armstrong, K., De Marie, A., Watanabe, Y., Tan, M., Travers, N. Prospective evaluation of FOLFIRINOX in neo-adjuvant treatment of gastro-oesophageal junction carcinomas. Annals of Oncology, 2 July 2019 
https://academic.oup.com/annonc/article/30/Supplement_4/mdz155.301/5526647

Dean, A., McNulty, M., Das, A. Third-line re-treatment of advanced pancreatic adenocarcinoma with gemcitabine and nab-paclitaxel. Annals of Oncology, Volume 30, 2 July 2019
https://academic.oup.com/annonc/article/30/Supplement_4/mdz155.302/5526656?searchresult=1

Dean, A., Das, A. Modifi ed FOLFIRINOX as a second-line treatment in pancreatic adenocarcinoma following gemcitabine plus nab-paclitaxel failure in patients with status two or less. Annals of Oncology, Volume 30, 2 July 2019 
https://academic.oup.com/annonc/article/30/Supplement_4/mdz155.303/5526663?searchresult=1 
 

You may be interested in